iCAD to Report Third Quarter 2021 Financial Results on Tuesday, November 9
Rhea-AI Summary
iCAD (NASDAQ: ICAD) will announce its third-quarter financial results on November 9, 2021, after market close. A conference call is scheduled for 4:30 PM ET, providing an opportunity for investors to gain insights into the company's performance in cancer detection and therapy solutions. The domestic and international call-in numbers are provided, along with a conference ID and a link for the webcast. iCAD continues to position itself as a leader in the medical technology sector.
Positive
- None.
Negative
- None.
News Market Reaction – ICAD
In the trading session that priced this news, ICAD declined 2.46%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NASHUA, N.H., Oct. 26, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter ended September 30, 2021, after the market close, and host a conference call at 4:30pm Eastern Time on Tuesday, November 9.
| Tuesday, November 9th at 4:30pm ET | |
| Domestic: | 855-327-6837 |
| International: | 631-891-4304 |
| Conference ID: | 10016811 |
| Webcast: | https://themediaframe.com/mediaframe/webcast.html?webcastid=cp8sjumj |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Relations:
Brian Ritchie, LifeSci Advisors
+ 1-212-915-2578
britchie@lifesciadvisors.com
